Email to SPL investor relations, page-29

Keep trying @Joelsmith2452 but unfortunately as you may recall it took me 4 emails and a threat to take my valid concerns about disclosure to ASX and ASIC for me to get a reply (and even that reply was fairly inept).

It is painfully clear that Starpharma need to employ more staff in their marketing and investor relations departments and the like. Even Starpharma’s social media pages as a single example (Instagram and Facebook) have not had an update since the 3rd of May. They have just died on a vine.

IMO Starpharma’s Viraleze costs incurred (R&D, Boston Consulting Group consulting, variant testing, associated manufacturing expenses, giveaways to Harlequins, product recall costs, lawyers fees and of course pending bonuses for Jackie Fairlie and the BOD for successfully launching a new product) have likely far exceeded income to Starpharma’s bank account from sales of product so far.

Jackie is STILL the queen of crumb throwing hopes and dreams to shareholders without being able to actually deliver, so far ….

GLTAH

P.S. I’m still topping up at these pre-EOFY share price levels but it’s through somewhat gritted teeth.

https://hotcopper.com.au/threads/viraleze-now-in-14-000-independent-pharmacies.6067295/page-42?post_id=53435033